Blog

Shares of Jazz Pharmaceuticals JAZZ rose nearly 21% on Monday after it announced positive top-line results from the late-stage HERIZON-GEA-01 study. This study evaluated different combination

Visa Inc. V is making waves in Europe as Beyond by RS2 steps up to become a Principal Issuing Member, a significant milestone that enhances V’s growing presence in the region’s rapidly expanding

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Williams-Sonoma (WSM), which belongs to

Molson Coors Beverage Company TAP is navigating one of the most challenging beer environments in recent years, as industry volume declines continue to weigh on overall performance. In 2025, U.S

Gorilla Technology Group Inc. GRRR announced third-quarter 2025 adjusted EPS of 24 cents, missing the Zacks Consensus Estimate by 7.7% and decreasing 17.2% from the year-ago level.

Total revenues

Mission Produce, Inc.’s AVO growing momentum in the U.K. marks a strategic turning point for the company as it extends its avocado leadership into high-potential international markets. After years

PLBY Group, Inc. (PLBY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of

Investors might want to bet on ADC Therapeutics SA (ADCT), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings

Virgin Galactic (SPCE) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of

Jade Biosciences, Inc. (JBIO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings

Ares Commercial Real Estate (ACRE) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings

ANI Pharmaceuticals (ANIP) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in

First Bank (FRBA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one

Oric Pharmaceuticals, Inc. (ORIC) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates

TriMas (TRS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of

Tokyo Electron Ltd. (TOELY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Celestica Inc. CLS recently expanded its AI infrastructure by introducing the SD6300 ultra-dense storage expansion system. The leading-edge storage platform is engineered to match the growing

United Parcel Service UPS and FedEx FDX, boasting sizable market capitalizations of $81.4 billion and $63.1 billion, respectively, dominate the Zacks Transportation—Air Freight and Cargo industry

Shares of Norwegian Cruise Line Holdings Ltd. NCLH have declined 28.2% in the past three months compared with the Zacks Leisure and Recreation Services industry’s 11.6% fall. Over the same

Helmerich & Payne, Inc. HP reported a fourth-quarter fiscal 2025 adjusted net loss of 1 cent per share, which substantially missed the Zacks Consensus Estimate of adjusted net income of 26 cents

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses from the stock lately, despite its bumpy ride over recent months. The San Francisco, CA-based health and

Shares of Ventyx Biosciences VTYX have skyrocketed 156% in the past month. The massive surge in the stock price was primarily driven by the success of the company’s mid-stage study evaluating its

Shares of Ampco-Pittsburgh Corporation AP have surged 31.4% since the company released results for the quarter ended Sept. 30, 2025, sharply outperforming the S&P 500 Index’s 3.3% decline over the